Nearly 60 years after it approved Darvon and Darvocet and started a chain of events that led to the two pain-killers becoming one of the most widely prescribed and commercially successful drugs the Food and Drug Administration announced that the drugs were being recalled out of concern for the safety of the consumers.
It was in November, 2010, that the FDA said the drugs were being recalled after numerous findings, including one by the drug’s own manufacturer at the direction of the FDA, showed that there could be a link between the use of Darvon and Darvocet and heart problems. According to the FDA, propoxyphene, which is the principal active component of the two drugs, can generate these problems whether or not the patient uses the recommended dosage or not. This action was requested many times in recent years by consumer groups and some medical researchers who vigorously voiced concerns over the safety of the two drugs and the possible negative effects they could have on consumers.
There have been a number of lawsuits filed against the manufacturer, Xanodyne Pharmaceutical Inc., over the years but the growing number of complaints, negative medical research and consumer activism has caused that number to swell in recent years. Lawyers who specialize in drug defect cases are representing victims without charging legal fees unless there are settlements or jury awards in these cases and they are conducting pre-trial evidence gathering to determine whether Xanodyne was aware of these dangers and did not inform the FDA or the public, which could make them liable for even higher damages.